BACKGROUND: Intrachromosomal amplification of chromosome 21 (iAMP21) is known to be associated with poor prognosis in B-cell ALL (B-ALL). To determine the frequency and clinical characteristics of iAMP21 in Korean B-ALL patients, we performed FISH and multiplex ligation-dependent probe amplification (MLPA) analyses. METHODS: A total of 102 childhood B-ALL patients were screened with ETV6-RUNX1 FISH probes (Abbott Molecular, USA). The presence of an iAMP21 was confirmed by using MLPA P327 iAMP21-ERG probemix (MRC Holland, The Netherlands). RESULTS: iAMP21 was detected in one of the screened B-ALL patients (1/102 patients, 1.0%) who presented the ALL immunophenotype and complex karyotype at initial diagnosis. The patient relapsed twice afte...
In addition to somatic mutations, germline genetic predisposition to hematologic malignancies is cur...
We have previously identified a unique subtype of acute lymphoblastic leukemia (ALL) associated with...
p>Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy, comprising approximate...
Intrachromosomal amplification of chromosome 21 (iAMP21) defines a distinct cytogenetic subgroup of ...
Intrachromosomal amplification of chromosome 21 (iAMP21) defines a distinct cytogenetic subgroup of ...
Intrachromosomal amplification of chromosome 21 (iAMP21) defines a distinct subgroup of childhood B-...
Intrachromosomal amplification of chromosome 21 (iAMP21) defines a distinct subgroup of childhood B-...
The intrachromosomal amplification of chromosome 21 (iAMP21) was identified as a novel and prognosit...
Patients with acute lymphoblastic leukemia (ALL) and an intrachromosomal amplification of chromosome...
Objectives: Intrachromosomal amplification of chromosome 21 (iAMP21) occurs in 2% of B-cell acute ly...
Chromosome abnormalities that usually define high-risk acute lymphoblastic leukemia are the t(9;22)/...
Intrachromosomal amplification of chromosome 21 (iAMP21), involving amplification of the RUNX1 gene ...
Patients with acute lymphoblastic leukaemia (ALL) and an intrachromosomal amplification of chromosom...
PURPOSE: To evaluate the effect on outcome of intensifying therapy for patients with acute lymphobla...
Pediatric B-cell acute lymphoblastic leukemia (B-ALL) is associated with various specific cytogeneti...
In addition to somatic mutations, germline genetic predisposition to hematologic malignancies is cur...
We have previously identified a unique subtype of acute lymphoblastic leukemia (ALL) associated with...
p>Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy, comprising approximate...
Intrachromosomal amplification of chromosome 21 (iAMP21) defines a distinct cytogenetic subgroup of ...
Intrachromosomal amplification of chromosome 21 (iAMP21) defines a distinct cytogenetic subgroup of ...
Intrachromosomal amplification of chromosome 21 (iAMP21) defines a distinct subgroup of childhood B-...
Intrachromosomal amplification of chromosome 21 (iAMP21) defines a distinct subgroup of childhood B-...
The intrachromosomal amplification of chromosome 21 (iAMP21) was identified as a novel and prognosit...
Patients with acute lymphoblastic leukemia (ALL) and an intrachromosomal amplification of chromosome...
Objectives: Intrachromosomal amplification of chromosome 21 (iAMP21) occurs in 2% of B-cell acute ly...
Chromosome abnormalities that usually define high-risk acute lymphoblastic leukemia are the t(9;22)/...
Intrachromosomal amplification of chromosome 21 (iAMP21), involving amplification of the RUNX1 gene ...
Patients with acute lymphoblastic leukaemia (ALL) and an intrachromosomal amplification of chromosom...
PURPOSE: To evaluate the effect on outcome of intensifying therapy for patients with acute lymphobla...
Pediatric B-cell acute lymphoblastic leukemia (B-ALL) is associated with various specific cytogeneti...
In addition to somatic mutations, germline genetic predisposition to hematologic malignancies is cur...
We have previously identified a unique subtype of acute lymphoblastic leukemia (ALL) associated with...
p>Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy, comprising approximate...